Humanwell Healthcare (group) Co.,ltd. Class ASSE: 600079

Announcement on Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection with Increased Indications

· Issued by Humanwell Healthcare (group) Co.,ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection with Increased Indications

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment